Recently, we took advantage of the power of mass cytometry to decipher the splenic LME of the Eμ-TCL1 mouse, the canonical model for CLL, which allowed us to identify specific immune cell populations and the immune checkpoints PD1 and LAG3 as potential targets in CLL (2). This evidence concerns the gene LAG3 and B-cell chronic lymphocytic leukemia.